The
global
pharmaceutical market is expected to grow at a CAGR of 5% during 2011-2017,
exceeding sales worth US$ 1.1 Trillion by 2017. This market, however, is
expected to undergo a number of transitions which would impact the course of
its growth. These transitions include a shift of growth from the developed to
the emerging markets, an increasing focus on biopharmaceuticals compared to
small molecule drugs and an increasing preference for generics compared to
their branded versions. As a result of these transformations; the need for a
user friendly, robust and comprehensive pharmaceutical market intelligence has
become imperative for investors, researchers, consultants, marketing
strategists, and all those who are planning to foray into the pharmaceutical
market in some form or the other.
IMARC
Group, one of the world’s leading research and advisory firms, introduces a new
and revolutionary way to understand and evaluate the global pharmaceutical
market with its Microsoft Excel based report entitled “Global Pharmaceutical
Market Report & Forecast: 2012-2017”. This report provides an analytical
and statistical insight into the global pharmaceutical market. The study, which
has been undertaken using desk based as well as primary market research has
analyzed the following aspects of the global pharmaceutical market.
To order this report @ http://www.rnrmarketresearch.com/global-pharmaceutical-market-report-forecast-2012-2017-market-report.html
What
We Have Achieved in This Report?
Regions
Covered: Global,
North America, Asia Pacific, Latin America & Caribbean and Middle East
& Africa
Countries
Covered in Each Region
North
America: United
States and Canada
Europe: Germany, France,
Italy, Spain, United Kingdom, Russia, Turkey, Netherlands, Poland, Greece,
Belgium, Switzerland, Austria, Sweden, Portugal, Hungary, Romania, Denmark,
Czech Republic, Finland, Ireland, Norway, Slovakia, Bulgaria, Croatia,
Slovenia, Lithuania, Latvia, Luxembourg and Estonia
Asia
Pacific: Japan,
China, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines,
Pakistan, Vietnam, Bangladesh, Hong Kong, New Zealand, Malaysia and Singapore
Latin
America & Caribbean: Brazil, Mexico, Venezuela, Argentina,
Puerto Rico, Colombia, Chile, Ecuador, Peru, Dominican Republic and Uruguay
Middle
East & Africa: South Africa, Egypt, Saudi Arab, Algeria, Morocco,
United Arab Emirates Lebanon, Tunisia, Jordan, Kuwait
Focus
of the Analysis:
- Historical sales performance (2007-2011) for each country
- Historical sales performance (2007-2011) for each region
- Sales forecast (2012-2017) for each country
- Sales forecast (2012-2017) for each region
- Sales performance of key manufacturers for each country (2007-2011)
- Sales performance of key therapeutic areas for each country (2007-2011)
- Country wise sales breakup for each region (2007-2011)
- Country wise sales breakup forecast for each region (2012-2017)
- What was the historical performance of the global pharmaceutical market?
- Which are the key regions and countries in the global pharmaceutical market?
- Which are the largest pharmaceutical markets in the world?
- Which are the fastest growing pharmaceutical markets in the world?
- Which markets are expected to witness the slowest growth in the coming years?
- Which countries represent the key markets for each region?
- What has been the performance of various therapeutic classes in each country?
- Who are the top pharmaceutical manufacturers in each country?
- What are the market shares of the top pharmaceutical manufacturers in each country?
- To gain a comprehensive understanding on the historical, current and future pharmaceutical market trends across 70 countries in 6 regions.
- To identify potential regions, countries, therapeutic areas, partners and competitors for market entry and expansion plans.
- As a tool for developing investment strategies by identifying the biggest winners and losers across various regions and countries.
- To ensure a successful M&A and partnership strategy by identifying therapeutic areas and companies with the most promising outlook.
Report
Details:
Published: Oct 2012
No. of
pages:
Price: Single User License: US$ 1400 Corporate User License: US$ 2000
No comments:
Post a Comment